International Stem Cell (ISCO) Revenue (2010 - 2026)
International Stem Cell's Revenue came in at $2.68 million for Q2 2026, up 9.3% from $2.45 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Revenue (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, International Stem Cell reported Revenue of $9.65 million, up 4.8% year-over-year; for FY2025, it was $9.1 million, up 0.2% from FY2024.
- Revenue carries a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- Going back by year, Revenue was $9.09 million in FY2024 (+16.6%), $7.79 million in FY2023 (-4.8%), $8.18 million in FY2022 (+14.0%) and $7.18 million in FY2021 (+0.7%).
- The Q2 2026 figure represents the highest quarterly Revenue since Q4 2019.
- Year-over-year, Revenue increased in five of the last seven quarters, with growth averaging 7.3%.
- The fastest year-over-year change in Revenue over five years came in Q4 2022 (growth of 31.9%), and the weakest in Q4 2023 (a decline of 22.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | International Stem Cell | 2.80 Mn | -1.17 Mn | 1.46 Mn | 2.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.68 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 1.89 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 2.09 Mn |
| Dec 31, 2022 | 2.43 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | 2.03 Mn |
| Mar 31, 2022 | 2.02 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 1.83 Mn |
API Access
International Stem Cell Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();